Default object view. Click to create a custom template, Node ID: 179686, Object ID: 107418

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

Tags: Early Early , Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

07/02/2017 5:25 pm

No